Model‐based evaluation of pulmonary pharmacokinetics in asthmatic and COPD patients after oral olodaterol inhalation-Reference-Cited by-同舟云学术

Model‐based evaluation of pulmonary pharmacokinetics in asthmatic and COPD patients after oral olodaterol inhalation

Published:2016-06-23 Issue:3 Volume:82 Page:739-753
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Borghardt Jens Markus¹²,Weber Benjamin²,Staab Alexander²,Kunz Christina²,Kloft Charlotte¹

Affiliation:

1. Institute of Pharmacy, Department of Clinical Pharmacy and BiochemistryFreie Universität Berlin 12169 Berlin Germany

2. Translational Medicine and Clinical PharmacologyBoehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.12999

Reference47 articles.

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD).Global Strategy for the Diagnosis Management and Prevention of Chronic Obstructive Pulmonary Disease 2015. Available athttp://www.goldcopd.it/materiale/2015/GOLD_Report_2015.pdf

2. Global Initiative for Asthma (GINA).Global strategy for asthma management and prevention 2016.http://ginasthma.org/2016-gina-report-global-strategy-for-asthma-management-and-prevention/

3. The inhalation device influences lung deposition and bronchodilating effect of terbutaline.

4. Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, Turbuhaler®

5. Population pharmacokinetic analysis of tiotropium in healthy volunteers after intravenous administration and inhalation;Parra‐Guillen Z;J Pharmacokinet Pharmacodyn,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically-based pharmacokinetic model for pulmonary disposition of protein therapeutics in humans;Journal of Pharmacokinetics and Pharmacodynamics;2022-10-20

2. Pulmonary Pharmacokinetics and Biophysics;Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases;2022

3. Factors Affecting Drug Exposure after Inhalation;Prague Medical Report;2022

4. In vitro and ex vivo models in inhalation biopharmaceutical research — advances, challenges and future perspectives;Advanced Drug Delivery Reviews;2021-10

5. Drivers of absolute systemic bioavailability after oral pulmonary inhalation in humans;European Journal of Pharmaceutics and Biopharmaceutics;2021-07